Smart Money Alert

Windlas Biotech Limited

DecreasedQuarterly

WINDLASPharmaceuticalsMarket Cap₹2K Cr

Stake

3.42% → 1.73%

Holding

3.57 L shares

Change

−3.49 L shares

As of

Sept 2026

Since alert−2.6%₹906.10 → ₹882.50

Nifty 50−0.6%

ICICI Prudential Mutual Fund

Mutual Fund

The move

ICICI Prudential Mutual Fund halved its stake in Windlas Biotech from 3.42% to 1.73%, selling 3,49,356 shares.

About Windlas Biotech Limited

+ Follow Visit stock

A leading pharmaceutical contract development and manufacturing organization, Windlas Biotech specializes in producing solid and liquid dosage forms for domestic and international clients. The company provides comprehensive CDMO services including product discovery, development, and commercial manufacturing of generic and complex generic medications. Its vertically integrated operations, technical capabilities, and focus on quality manufacturing distinguish it within India's pharmaceutical sector.

About ICICI Prudential Mutual Fund

+ Follow Visit investor

India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.

Get the next move the moment it happens.

Follow ICICI Prudential Mutual Fund and Windlas Biotech Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Windlas Biotech Limited shareholders ICICI Prudential Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Windlas Biotech Limited

Bandhan Mutual FundExited

Bandhan Mutual Fund has slipped off the disclosed shareholder list for Windlas Biotech Limited this quarter, having either fully exited the previous 1.43 percent stake or trimmed the holding below the 1 percent reporting threshold.

17 Oct 2026

Bandhan Mutual FundIncreased

Bandhan Mutual Fund increased its stake in Windlas Biotech Limited from 1.11% to 1.43% by buying 61,858 shares. The stake is worth ₹25.13 Cr based on the company's share price of ₹852.25.